Can gastrodin calm RA by blocking histone lactylation?
Gastrodin bound KAT8 (KD 413.72 μM), lowered H3K9la, cut IL-6/MMP signals in FLS and THP-1 cells, and eased joint swelling in AIA rats at 20 mg/kg.
Source
Gastrodin attenuates rheumatoid arthritis by targeting KAT8 to inhibit the lactylation of H3K9
Study at a glance
- Design
- Animal / in-vitro — LPS-stimulated FLS/THP-1 cultures plus Sprague-Dawley rat adjuvant-induced arthritis; docking/SPR targeting KAT8
- N
- N=5 · AIA rats randomly grouped n=5 per group (AIA, GAS, DEX); plus in vitro FLS and THP-1 macrophage assays
- Population
- Rheumatoid-arthritis models: fibroblast-like synoviocytes, THP-1 macrophages, and SD rat AIA
- Outcome
- Inflammatory cytokines/MMPs, H3K9 lactylation, KAT8 stability, and joint swelling/synovial hyperplasia
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
Treated LPS-stimulated FLS and THP-1 macrophages with gastrodin (10–20 μM), confirmed KAT8 binding by docking and SPR, manipulated KAT8, and tested 20 mg/kg gastrodin in Sprague-Dawley AIA rats.
What they found
GAS inhibited IL-6, MMP1, and MMP13 via lower glycolysis/lactate. SPR KD was 413.72 μM. GAS destabilized KAT8 and reduced H3K9la. In AIA rats, 20 mg/kg lessened swelling and synovial hyperplasia with lower H3K9la and IL-6.
The limits
What it doesn't show
Cell and rat AIA data do not equal a human RA trial; micromolar SPR affinity is modest, so clinical dosing and safety are unproven.
Key terms
- Gastrodin (GAS)
- Phenolic glycoside from Gastrodia elata tested here as an RA candidate.
- KAT8
- Lysine acetyltransferase 8, a lactoyltransferase target of gastrodin.
- H3K9la
- Histone H3 lysine-9 lactylation linked to inflammatory gene programs.
- FLS
- Fibroblast-like synoviocytes that drive synovial inflammation in RA.
- AIA
- Adjuvant-induced arthritis rat model of inflammatory joint disease.
- SPR
- Surface plasmon resonance used to measure GAS–KAT8 binding (KD 413.72 μM).
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
Gastrodin’s histone mark target was:
Common questions
What did gastrodin target?
KAT8, reducing H3K9 lactylation.
In-vitro concentrations?
10–20 μM in FLS and THP-1 macrophages.
Rat dose?
20 mg/kg in Sprague-Dawley AIA.
SPR affinity?
KD 413.72 μM for GAS–KAT8.
More on Rheumatology